Overview
PureTech is a clinical stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and inflammatory and immunological diseases, among others.
For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.
For more information, please use the links to the right.
View our corporate deck.
Share Price
Half Year Report 2020
Corporate Presentation
Cash at PureTech Parent Level
$412.1M PureTech Level Pro-Forma Cash Reserves as of August 26, 20201
$310.5M PureTech Level Cash Reserves as of June 30, 2020 (prior to monetization of Founded Entity equity); Cash runway into Q1 20242
1. PureTech Level Pro-Forma Cash Reserves is an alternative performance measure (APM) which includes the PureTech Level Cash Reserves of $310.5 million at June 30, 2020 and the $101.6 million in proceeds from the August 26, 2020 sale of 1.3 million Karuna common shares.
2. PureTech Level Cash Reserves at June 30, 2020 represent cash balances and short-term investments held at PureTech Health LLC, PureTech Management, Inc., PureTech Health PLC, PureTech Securities Corporation of $284.2 million and held at PureTech LYT Inc., our internal pipeline, of $26.3 million, all of which are wholly owned entities of PureTech, excluding cash balances and short-term investments of Controlled Founded Entities which are not wholly owned.
SOLICITORS
DLA Piper UK LLP
3 Noble Street
London EC2V 7EE
United Kingdom
TEL: +44 870 011 1111
INDEPENDENT AUDITOR
KPMG LLP
15 Canada Square
London E14 5GL
United Kingdom
TEL: +44 207 311 1000
MEDIA / PR
FTI Consulting, Inc.
200 Aldersgate
Aldersgate Street
London EC1A 4HD
United Kingdom
TEL: +44 203 727 1000
Computershare Investor Services PLC
The Pavilions, Bridgwater Road
Bristol BS99 6ZZ
United Kingdom
Telephone UK: 0800 408 0094
Telephone Overseas: +44 870 889 3159
Email: web.queries@computershare.co.uk
PETER WELFORD
Jefferies International Limited
68 Upper Thames Street
London EC4V 3BJ
United Kingdom
TEL: +44 (0)20 7029 8000
AMY WALKER
Peel Hunt LLP
Moor House
120 London Wall
London EC2Y 5ET
United Kingdom
TEL: +44 (0)20 7418 8900
ALISTAIR CAMPBELL
Liberum
Ropemaker Place
25 Ropemaker Street
London EC2Y 9LY
United Kingdom
TEL: +44 (0)20 3100 2096